The pain department of the First Central Hospital of Tianjin has taken the lead in shouldering the heavy responsibility of the pain department of the First Central Hospital of Tianjin, Zheng Baosen [Our reporter: Xiaojun] Postherpetic neuralgia is one of the most common and difficult to cure chronic pain diseases in the elderly. The first symposium on the treatment of neuropathic pain in northern China and the finalization of the multicenter research program for the demonstration of postherpetic neuralgia intervention of the National Science and Technology Support Program was successfully concluded in Tianjin recently by the pain department of the First Central Hospital of Tianjin. At the meeting, Prof. Han Jisheng, academician of Chinese Academy of Sciences and the first director of the Chinese Medical Association Pain Branch, Prof. Fan Bifa, former director of the Chinese Medical Association Pain Branch, Prof. Chen Jun, director of the Institute of Pain Research of the Fourth Military Medical University, and other experts from more than 10 domestic The first multi-center research program in China was developed by experts from all over the country, who showed their own technical “tricks” for the treatment of postherpetic neuralgia, which was warmly welcomed by more than 200 experts present. Professor Zheng Baosen, a pain doctor at the First Central Hospital in Tianjin, who first researched adriamycin intervention for post-herpetic neuralgia in China, showed that post-herpetic neuralgia can be effectively treated after 16 years of animal experiments and clinical research. The This technology will be clinically validated in 16 university hospitals in China from this year, and will be fully summarized and promoted in the 2nd Northern China Neuropathic Pain Treatment Symposium to be held in Tianjin in the coming year.